AMMF Grants for Research

One of AMMF’s major objectives is to support specialised research teams in their work to find the causes, methods of earlier diagnosis, and effective treatments for cholangiocarcinoma (CC).

Since its inception in 2002, AMMF has awarded in excess of £0.5m (half a million pounds sterling) in grants to support research at many of the UK’s leading research institutions.

AMMF has been or is currently supporting research at: Imperial College London, University College London, The Institute of Hepatology London, University of Birmingham, University of Cambridge, University of Edinburgh, University of Nottingham, University of East Anglia.

AMMF welcomes funding applications from research bodies for cholangiocarcinoma work.

The following is research AMMF is currently supporting:


The University of Edinburgh

Professor Stuart Forbes
Award:  £70,000
To fund work on the potential of Notch and Wnt as therapeutic targets in cholangiocarcinoma.

Read More
1-professor-stuart-forbes


Institute of Genetics & Molecular Medicine
(The University of Edinburgh)

Dr Luke Boulter
Award: £33,000
For work towards “Discovering driver mutations in cholangiocarcinoma using forward genetics”

Read More
2-dr-luke-boulter

University College London

Dr Hayley Whitaker
Award:  £10,400
To help fund Dr Hayley Whitaker’s team in their work on the BI-010 biomarker (this is a 2nd grant for this work).

Read More
3-dr-haley-whitaker

University College London

Research Fellow – Dr Jonathan Kay
Award:  £54,976
A Research Fellowship awarded to Dr Jonathan Kay, working with Dr Hayley Whitaker’s team on the BI-010 project.

Read More
4-dr-jonathan-kay

University of East Anglia
(Norfolk & Norwich University Hospital)

Dr Simon Rushbrook
Award:  £39,249
To fund work on “The Role of NRF2 in the Pathogenesis of Cholangiocarcinoma”

Read More
5-dr-simon-rushbrook

The University of Manchester

Professor Juan Valle
Award:  £21,818
Given towards project management costs for the ABC-06 clinical trial.

Read More
Professor Juan Valle

Aintree University Hospital, Liverpool

Mr Hassan Malik
Award:  £2,000
A small grant awarded to assist with the hENT1 biomarker work.

Read More
Mr Hassan Malik

University of Nottingham

Professor David Bates
Award:  £1,500
A small grant awarded to fund a 2nd year BSc student working on an existing project investigating EGFR inhibitors.

Read More
6-professor-david-bates

Recently completed grants

Imperial College London

Dr Shahid Khan
Award:  £30,000
Given to assist funding the establishment of a cholangiocarcinoma biobank, including technician funding, and equipment ( -80º­ fridge, an encrypted computer, consumables).

Read More
7-dr-shahid-khan

Institute of Hepatology

Research Fellow – Dr Gemma Choy
Award:  £82,060
A Research Fellowship awarded to Dr Gemma Choy, to enable her to continue work on MAPK-targeted therapy for intrahepatic cholangiocarcinoma.

Read More
8-dr-gemma-choy

Institute of Hepatology

Dr Salvatore Papa
Award:  £34,800
A grant awarded to Dr Papa to assist with work on the molecular development of intrahepatic cholangiocarcinoma.

Read More
dr-salvator-papa

Imperial College London

Research Fellow – Dr Abigail Zabron
Award:  £65,904
A Research Fellowship awarded to Dr Zabron for to enable her to continue the work into cholangiocarcinoma proteomics and genetics.

Read More
10-dr-abigail-zabron

Imperial College London

Dr Simon Ralphs
Award:  £29,758
A Research Fellowship awarded to Dr Ralphs, for collaborative work with Thailand on a urinary biomarker for cholangiocarcinoma.

Read More
11-dr-simon-ralphs

The BILCAP Trial

Award:  £14,000
Given to help support the BILCAP trial.
(This trial closed to recruitment at the end of 2015, and is due to report at the ASCO annual meeting in Chicago June 2017)

Read More

Information on AMMF supported research

AMMF’s Terms and Conditions for the award of Research Grants
One of AMMF’s major objectives is to support specialised research teams in their work to find the causes, methods of earlier diagnosis, and effective treatments for cholangiocarcinoma (CC).

AMMF welcomes funding applications from research bodies for cholangiocarcinoma work.

To read the Terms and Conditions under which AMMF’s grants are awarded, click here

The use of animals in research
To read AMMF’s position on the use of animals in cholangiocarcinoma research, click here

 

January 2017

Bookmark and Share